Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30271
Title: | Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice | Authors: | DEWACHTER, Ilse Reversé, Delphine Caluwaerts, Nathalie Ris, Laurence Kuipéri, Cuno Van den Haute, Chris Spittaels, Kurt Umans, Lieve Serneels, Lutgarde Thiry, Els Moechars, Dieder Mercken, Mark Godaux, Emile Van Leuven, Fred |
Issue Date: | 2002 | Publisher: | SOC NEUROSCIENCE | Abstract: | In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques. A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase. Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production. By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology. In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments. In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old. This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months. In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice. The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice. Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice. This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity. In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain. | Keywords: | PS1;Alzheimer’s disease;neuronal plasticity;cognition;amyloid pathology;mouse model | Document URI: | http://hdl.handle.net/1942/30271 | ISSN: | 0270-6474 | e-ISSN: | 1529-2401 | ISI #: | 000175296200022 | Rights: | 2002 Society for Neuroscience | Category: | A1 | Type: | Research Report |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3445.full.pdf | 461.66 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
198
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
207
checked on Oct 4, 2024
Page view(s)
32
checked on Sep 7, 2022
Download(s)
8
checked on Sep 7, 2022
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.